Cubist Systematic Strategies’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-86,348
| Closed | -$132K | – | 1473 |
|
|
2025
Q1 | $132K | Sell |
86,348
-169,744
| -66% | -$260K | ﹤0.01% | 1235 |
|
|
2024
Q4 | $635K | Buy |
256,092
+249,121
| +3,574% | +$618K | ﹤0.01% | 929 |
|
|
2024
Q3 | $8.02K | Sell |
6,971
-37,812
| -84% | -$43.5K | ﹤0.01% | 1356 |
|
|
2024
Q2 | $49.3K | Sell |
44,783
-119
| -0.3% | -$131 | ﹤0.01% | 1235 |
|
|
2024
Q1 | $55.7K | Sell |
44,902
-90,393
| -67% | -$112K | ﹤0.01% | 1900 |
|
|
2023
Q4 | $142K | Buy |
135,295
+92,271
| +214% | +$96.9K | ﹤0.01% | 1720 |
|
|
2023
Q3 | $295K | Sell |
43,024
-15,897
| -27% | -$109K | ﹤0.01% | 1423 |
|
|
2023
Q2 | $611K | Buy |
58,921
+3,946
| +7% | +$40.9K | ﹤0.01% | 1337 |
|
|
2023
Q1 | $445K | Buy |
+54,975
| New | +$445K | ﹤0.01% | 1857 |
|
|
2022
Q4 | – | Sell |
-8,109
| Closed | -$128K | – | 3229 |
|
|
2022
Q3 | $128K | Sell |
8,109
-941
| -10% | -$14.9K | ﹤0.01% | 3141 |
|
|
2022
Q2 | $126K | Buy |
9,050
+5,621
| +164% | +$78.3K | ﹤0.01% | 3348 |
|
|
2022
Q1 | $59K | Sell |
3,429
-17,583
| -84% | -$303K | ﹤0.01% | 3324 |
|
|
2021
Q4 | $306K | Buy |
21,012
+2,012
| +11% | +$29.3K | ﹤0.01% | 2782 |
|
|
2021
Q3 | $342K | Sell |
19,000
-34,257
| -64% | -$617K | ﹤0.01% | 2278 |
|
|
2021
Q2 | $935K | Sell |
53,257
-10,945
| -17% | -$192K | 0.01% | 1621 |
|
|
2021
Q1 | $1.62M | Buy |
+64,202
| New | +$1.62M | 0.02% | 1190 |
|
|
2019
Q4 | – | Sell |
-10,533
| Closed | -$11K | – | 2389 |
|
|
2019
Q3 | $11K | Sell |
10,533
-500
| -5% | -$522 | ﹤0.01% | 2142 |
|
|
2019
Q2 | $24K | Sell |
11,033
-10,115
| -48% | -$22K | ﹤0.01% | 2377 |
|
|
2019
Q1 | $127K | Sell |
21,148
-64,914
| -75% | -$390K | ﹤0.01% | 1941 |
|
|
2018
Q4 | $636K | Buy |
+86,062
| New | +$636K | 0.03% | 808 |
|
|
2018
Q2 | – | Sell |
-8,361
| Closed | -$146K | – | 1756 |
|
|
2018
Q1 | $146K | Buy |
8,361
+7,009
| +518% | +$122K | 0.01% | 1508 |
|
|
2017
Q4 | $33K | Sell |
1,352
-4,165
| -75% | -$102K | ﹤0.01% | 1809 |
|
|
2017
Q3 | $142K | Buy |
+5,517
| New | +$142K | 0.01% | 1551 |
|